Related Insights
ACA Subsidy Cuts and Medical Device Demand: What the Regulatory Ripple Means for Healthcare Supply Chains
ACA subsidy reductions are emerging as a factor affecting medical procedure growth, with implications for medical device demand and healthcare manufacturing. Procurement professionals should understand how healthcare policy changes can influence purchasing patterns across the pharmaceutical and medical technology sectors.
The EU Green Deal's Chemical Strategy for Sustainability: What Has Been Retained and What Has Changed
The EU's Chemicals Strategy for Sustainability remains an important foundation for chemical regulation, but implementation has evolved alongside newer competitiveness initiatives. Here's what procurement professionals should understand for compliance planning in the second half of 2026.
Responsible Care in the Chemical Industry: What the Global Initiative Covers
Responsible Care is one of the chemical industry's longest-running voluntary sustainability initiatives. Understanding what membership represents, and how it differs from formal certification schemes, helps procurement professionals make better supplier evaluations.
Carbon Border Adjustment Mechanism: What Chemical Exporters Must Report During the Transitional Phase
The EU Carbon Border Adjustment Mechanism introduces new reporting responsibilities for importers and their non-EU suppliers. This guide explains which products are covered, what emissions data must be collected and how procurement teams can prepare for CBAM compliance.
CBAM Q2 2026 Reporting Deadline: What Chemical Exporters Must Submit Before July 31
EU’s Carbon Border Adjustment Mechanism (CBAM) Q2 2026 reporting deadline falls on July 31. Chemical exporters must compile verified embedded‑carbon data for their products, align with EU ETS rules, and submit the required CBAM declarations to avoid penalties.
TSCA Week 1 Post-Expiry Assessment: Chemical Companies Face Longer EPA Review Timelines
With the TSCA fee authority ending on June 22, chemical firms must brace for extended EPA review periods under the OPPT framework. This post outlines what companies can expect in the next 12 months and highlights key compliance steps before the 2026 TSCA reauthorization debate.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.